Mesoblast Limited (LWB) Stock Statistics & Valuation Metrics

Mesoblast Limited has a market cap or net worth of CHF1.51B. The enterprise value is CHF3.52K.

Mesoblast Limited has 1,298,748,200 shares outstanding. The number of shares has decreased by -2.65% in one year.

Mesoblast Limited’s return on equity (ROE) is -0.17 and return on invested capital (ROIC) is -8.45%.

The current PE Ratio of Mesoblast Limited is ―. Mesoblast Limited’s PEG ratio is -27.18.

In the last 12 months, Mesoblast Limited had revenue of 17.20M and earned -102.14M in profits. Earnings per share was -0.09.

In the last 12 months, operating cash flow was -59.76M and capital expenditures -1.11M, giving a free cash flow of -60.87M billion.

Mesoblast Limited pays an annual dividend of ―, resulting in a dividend yield of ―

Mesoblast Limited upcoming earnings date is Sep 2, 2026, TBA (Confirmed).

Mesoblast Limited as a current ratio of 1.99, with Debt / Equity ratio of 23.52%

In the past 12 months, Mesoblast Limited has paid 330.00K in taxes.

Mesoblast Limited EV to EBITDA ratio is -16.47, with an EV/FCF ratio of -23.94.

Mesoblast Limited has CHF129.57M in cash and marketable securities with CHF135.14M in debt, giving a net cash position of -CHF5.57M billion.

Gross margin is -53.34%, with operating margin of -363.08%, and net profit margin of -593.92%.

The average price target for Mesoblast Limited is CHF2.02, which is 11.43% higher than the current price. The consensus rating is Strong Buy